Patent Assignment
Reel/Frame 049000/0442
Assignment of Assignor's Interest
Recorded: 2019-04-25
Pages: 4
Assignor
PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Executed: 2018-11-08
Assignee
TEIJIN PHARMA LIMITED
KASUMIGASEKI COMMON GATE WEST TOWER, 2-1, KASUMIGASEKI 3-CHOME, CHIYODA-KU, TOKYO, 100-8585, JAPAN
Covered Property
(1)
Crystal of Quinoline Derivative
Application:
16/302,553 →
Publication:
US 2019/0276405
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 25, 2019
From: TEIJIN PHARMA LIMITED
To: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Reel/Frame 049000/0449 →
Assignment of Assignor's Interest
Apr 25, 2019
From: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
To: GB001, INC.
Reel/Frame 049000/0510 →
Assignment of Assignor's Interest
Apr 25, 2019
From: DALEY, DONALD JOHN; MONTANA, JOHN GARY; HYND, GEORGE
To: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Reel/Frame 049249/0375 →
Security Interest
May 3, 2019
From: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049081/0335 →
Assignment of Assignor's Interest
Jul 23, 2019
From: TERAMOTO, MITSURU; ITO, TAKAHIRO
To: TEIJIN PHARMA LIMITED
Reel/Frame 049835/0122 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 49081/0335
May 3, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.
Reel/Frame 067310/0307 →